A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease
Clinical trial NCT06015841 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06015841
- Sponsor
- AC Immune SA
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-24
- Primary completion
- 2028-01-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.